THE Biden Administration says Medicare beneficiaries will save about $1.5 billion in direct drug costs to treat diabetes, heart disease, types of arthritis and other illnesses under new prices negotiated with pharmaceutical companies that will come into force in 2026.
Savings range from 79% for Januvia, used to treat diabetes, to 38% for Imbruvica, used to treat blood cancers. This is the cost of the drug before any discounts or rebates are applied, but not the price people actually pay when filling their prescriptions.
A look at medications and negotiated prices.
Manufacturer: Merck Sharp Dohme
Conditions: Diabetes
Negotiated price: $113 for a 30-day supply
Reduction: 79%
Manufacturer: Novo Norodisk
Conditions: Diabetes
Negotiated price: $119 for a 30-day supply
Reduction: 76%
Manufacturer: AstraZeneca AB.
Conditions: Diabetes, heart failure and chronic kidney disease
Negotiated price: $178.50 for a 30-day supply
Reduction: 68%
Manufacturer: Immunex Corp.
Conditions: Rheumatoid arthritis, psoriasis, and psoriatic arthritis
Negotiated price: $2,355 for a 30-day supply
Reduction: 67%
Manufacturer: Boehringer Ingelheim
Conditions: Diabetes, heart failure and chronic kidney disease
Negotiated price: $197 for a 30-day supply
Reduction: 66%
Manufacturer: Janssen Biotech Inc.
Conditions: Psoriasis, psoriatic arthritis, Crohn’s disease, ulcerative colitis
Negotiated price: $4,695 for a 30-day supply
Reduction: 66%
Manufacturer: Janssen Pharms
Conditions: Prevention and treatment of blood clots. Risk reduction for patients with coronary or peripheral artery disease
Negotiated price: $197 for a 30-day supply
Reduction: 62%
Manufacturer: Bristol Myers Squibb
Conditions: Prevention and treatment of blood clots
Negotiated price: $231 for a 30-day supply
Reduction: 56%
Manufacturer: Novartis Pharms Corp.
Conditions: Heart failure
Negotiated price: $295 for a 30-day supply
Reduction: 53%
Manufacturer: Farmacíclica LLC
Conditions: blood cancer
Negotiated price: $9,319 for a 30-day supply
Savings: 38%
This story originally appeared on ABCNews.go.com read the full story